All In Biotech

Drug Trial Radar · NCT05507216

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 636 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

636

Actual

Start

Jan 25, 2023

Primary completion

Jun 24, 2025

Study completion Jul 15, 2025

Sponsor

Lead sponsor
Abivax S.A.Industry
Sponsor type
Industry
First posted
Aug 18, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].

Conditions

  • Ulcerative Colitis

Interventions

  • ABX464Drug

    Administered once daily in the morning with food

  • PlaceboDrug

    Administered once daily in the morning with food

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects Who Achieve Clinical Remission Per Modified Mayo Score at Week 8Time frame: 8 weeks

Locations

262 sites in 27 countries. Site status is shown where the registry gives one.

  • University of Alabama -Birmingham

    Birmingham, Alabama

  • Research Solutions of Arizona, PC

    Litchfield Park, Arizona

  • Applied Research Center of Arkansas

    Little Rock, Arkansas

  • National Institute of Clinical Research

    Bakersfield, California

  • Citrus Valley Gastroenterology

    Covina, California

  • United Medical Doctors

    Murrieta, California

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California

  • Clinical Applications Laboratories

    San Diego, California

  • Santa Maria Gastroenterology Medical Group

    Santa Maria, California

  • Danbury Hospital

    Danbury, Connecticut

  • West Central Gastroenterology d/b/a Gastro Florida

    Clearwater, Florida

  • IHS Health

    Kissimmee, Florida

  • Research Associates of South Florida

    Miami, Florida

  • Sanchez Clinical Research, Inc

    Miami, Florida

  • Wellness Clinical Research

    Miami Lakes, Florida

  • Sarkis Clinical Trials - Parent

    Ocala, Florida

  • AdventHealth Medical Group

    Orlando, Florida

  • Arnold Palmer Hospital For Children

    Orlando, Florida

  • Omega Research Orlando, LLC

    Orlando, Florida

  • Advanced Medical Research Center

    Port Orange, Florida

  • GCP Clinical Research, LLC

    Tampa, Florida

  • University of South Florida - PARENT

    Tampa, Florida

  • The University of Iowa

    Iowa City, Iowa

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas

  • Tandem Clinical Research, LLC

    Marrero, Louisiana

  • University of Michigan

    Ann Arbor, Michigan

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan

  • BVL Clinical Research

    Liberty, Missouri

  • Premier Health Research

    Sparta, New Jersey

  • NY Scientific Corp.

    Brooklyn, New York

  • Mount Sinai

    New York, New York

  • Plains Clinical Research Center, LLC

    Fargo, North Dakota

  • Susquehanna Research Group, LLC

    Harrisburg, Pennsylvania

  • Frontier Clinical Research, LLC

    Uniontown, Pennsylvania

  • Rapid City Medical Center, LLC

    Rapid City, South Dakota

  • Digestive Health Research, LC

    Hermitage, Tennessee

  • Texas Clinical Research Institute, LLC

    Arlington, Texas

  • Inquest Clinical Research

    Baytown, Texas

  • Gastroenterology Consultants of South Texas, PA

    Harlingen, Texas

  • Digestive System Healthcare

    Pasadena, Texas

Showing 40 of 262 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.